Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.393, 2002-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Meningococcal serogroup C vaccination programme well worth it in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 358, 2002-01 ,pp. :
Access to resources
Recommend
Which Dutch meningococcal group C vaccination programme?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 469, 2005-01 ,pp. :
Economic evaluations valuable in meningococcal vaccination
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 488, 2005-01 ,pp. :
Meningococcal Vaccination: Cui Bono?
PharmacoEconomics, Vol. 23, Iss. 4, 2005-01 ,pp. :
Infant meningococcal vaccination cost effective in Brazil
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 645, 2012-01 ,pp. :